FdaApplication
BLA 761037
Identifiers
- fda_app_no: BLA761037
Properties
| Property | Value |
|---|---|
| applicant_name | Sanofi-Aventis U.S. LLC |
| application_type | BLA |
| approval_date | 2017-05-22 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| KEVZARA | SARILUMAB | 150MG/1.14ML | Injection |
| KEVZARA | SARILUMAB | 200MG/1.14ML | Injection |
| KEVZARA | — | 200MG/1.14ML | Injection |
| KEVZARA | — | 150MG/1.14ML | Injection |
4 products